Other News

Zylox-Tonbridge enters into strategic cooperation with Hicicare for innovative Chinese vascular guidewires solutions

HANGZHOU, China, April 23, 2023 /PRNewswire/ — Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK, the “Company”) announced the signing of a strategic agreement with Guangdong Hicicare Science Co., Ltd. (“Hicicare”). With the collaboration, Zylox-Tonbridge and Hicicare plan to introduce and help accelerate the commercialization of co-branded vascular guidewire products in the neuro- […]

Capital Health Performs First Watchman Implant

Minimally invasive procedure dramatically reduces stroke risk for certain atrial fibrillation patients HOPEWELL, N.J., April 21, 2023 /PRNewswire/ — Physicians and staff from Capital Health’s Heart and Vascular Institute recently performed their first Watchman implant procedure at Capital Health Regional Medical Center in Trenton, New Jersey. Left atrial appendage closure, which includes the […]

Philips delivers solid operational performance as supply chain improves and actions to enhance execution start to take effect

First-quarter highlights Group sales increased to EUR 4.2 billion, with 6% comparable sales growth Comparable order intake growth was flat, with double-digit growth in the Diagnosis & Treatment businesses, offset by a decline in the Connected Care businesses Income from operations amounted to a loss of EUR 583 million, mainly […]

Picard Medical and its Subsidiary, SynCardia Systems, a Pioneer in Total Artificial Heart Technology, to Become a Publicly Traded Company via Merger with Altitude Acquisition Corp.

SynCardia Manufactures and Distributes the First-and-Only Commercially Available and FDA Approved Total Artificial Heart SynCardia is Entering a Rapid Growth Phase Supported by New Product Development, Label Expansion, and International Growth Transaction Estimates a Pre-Money Enterprise Value of $480 Million for Picard Medical Picard Medical Stockholders Will Roll 100% of Their Existing […]

HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge (NASDAQ: IVCP) With Goal to Transform Cardiovascular Disease Treatment

NEW YORK & VERO BEACH, Fla.–(BUSINESS WIRE)–NASDAQ IVCP Swiftmerge Acquisition Corp (“Swiftmerge”), a $225 million innovative healthcare investment corporation and a special purpose acquisition company, announced today the signing of a non-binding letter of intent (“LOI”) for a business combination with HDL Therapeutics Inc. (“HDL Therapeutics”), a privately held commercial […]

First Coast Cardiovascular Institute Announces Partnership With Cardiovascular Logistics

JACKSONVILLE, Fla.–(BUSINESS WIRE)–First Coast Cardiovascular Institute (FCCI) announced today that it is partnering with national cardiology platform, Cardiovascular Logistics (CVL), to enhance and expand its cardiovascular care and services throughout Northern Florida & Southern Georgia. CVL is the most comprehensive cardiovascular platform in the country. By partnering with CVL, FCCI […]

CWRU and UH researchers secure $6.2 million from NIH to investigate using artificial intelligence to predict cardiovascular disease

Researchers from Case Western Reserve University and University Hospitals Cleveland Medical Center (UH) have secured $6.2 million from two grants awarded in the same month from the National Institutes of Health (NIH) to predict cardiovascular disease through new artificial intelligence (AI) approaches. The study will employ cutting-edge AI techniques using machine- and deep-learning models to recognize […]

Semler Scientific Announces Appointment of Eric Semler and William Chang as Directors

Eric Semler Appointed as Chairman SANTA CLARA, Calif., April 19, 2023 /PRNewswire/ — – Semler Scientific, Inc. (Nasdaq: SMLR) today announced that Eric Semler and William H.C. Chang (together, the “Investors”), who collectively beneficially own more than 20% of Semler Scientific’s outstanding shares, will immediately join Semler Scientific’s board of directors as new independent directors. Mr. Semler […]

Cercare Medical brings their Neurovascular Clinical Workflows into ConcertAI’s TeraRecon Eureka Clinical AI Platform in new Partnership

New partnership incorporates latest perfusion technology into neurological CT and MR imaging CAMBRIDGE, Mass., April 20, 2023 /PRNewswire/ — The Eureka Clinical AI platform from ConcertAI’s TeraRecon provides clinicians with the state-of-the-artand deep learning technologies to deliver next-level CT and MR imaging through Cercare Perfusion, a fully-automated, simple-to-use, patient-specific perfusion software. Brain […]